Dr Petracek to Teach at DIA Benefit/Risk Management Course
Mar 2, 2015
In March of this year PharmInvent CEO Dr Jan Petracek will offer his bi-annual training on the topic of Benefit/Risk Management to be held in Hamburg from March 10 to March 11 2015.
Dr. Petracek will be joined by renowned expert in risk assessment, Dr. Michael Forstner former chair of the Risk Management Working Group for Roche. Dr Petracek, who is the Former Head of Risk Management at European Medicines Agency (EMA) and Dr. Forstner will combine their knowledge-base to deliver intensive lectures on such topics as:
- safety, efficacy, and effectiveness profiles of drugs
- planning safety and efficacy follow-up systems
- optimizing benefits and minimizing risks of products, including the best practices for the use of an evidence-based toolbox
The course has excellent feedback from previous years:
"The best part of the program are the real examples, practical questions and most importantly the exercises that make attendees live the situation and force them to go through interesting situations."
"The course was excellent."
For more information about the course, please visit the DIA website.